Akram Belghith, None;
Christopher Bowd, None;
Felipe Medeiros, Allergan, Inc. (C), Carl Zeiss Meditec Inc. (R), Alcon Laboratories Inc (R), Alcon Laboratories Inc. (F), Allergan Inc (F), Allergan Inc. (R), Bausch & Lomb (F), Carl Zeiss Meditec Inc (F), Carl-Zeiss Meditec, Inc (C), Heidelberg Engineering, Inc (F), Merck Inc (F), National Eye Institute (F), Novartis (C), Reichert Inc (R), Reichert, Inc (F), Sensimed (F), Topcon, Inc (F);
Robert Weinreb, Novartis (F), Aerie (F), Alcon (C), Allergan (C), Amkem (C), Bausch&Lomb (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec, (C), EyeTechCare (C), Genentech (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Nidek (F), Optovue (F), Quark (C), Sensimed (C), Solx (C), Topcon (C), Topcon (F);
Linda Zangwill, Carl Zeiss Meditec Inc (F), Heidelberg Engineering GmbH (F), Heidelberg Engineering GmbH (R), Optovue Inc (F), Topcon Medical Systems Inc (F)